RecruitingNCT06220136

Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex

Comparison of the Performances of the Train-of-Four Ratio and the Modified Train-of-Four Ratio During Reversal of Deep Neuromuscular Blockade With Sugammadex


Sponsor

Ankara University

Enrollment

199 participants

Start Date

Jun 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

It is known that deep neuromuscular block improves surgical conditions, especially during laparoscopic abdominal surgery. Based on this, in the Perioperative Neuromuscular Blockade Management guide published by the ESAIC association in 2022, it is recommended to deepen the level of neuromuscular blockade in cases where surgical conditions need to be improved. Sugammadex should be used to quickly and reliably reverse deep neuromuscular blockade. TOFScan, a 3-dimensional acceleromyograph for neuromuscular monitoring, has become widely used in recent years. With this monitor, it has been shown that in addition to the classical train-of-four ratio (cTOFR), the modified train-of-four ratio (mTOFR) can be used during the spontaneous recovery of nondepolarizing neuromuscular blockade. In a study conducted by Schmartz et al. in 2021, it was shown that mTOFR, which is the ratio of T4 to the reference stimulus, was compiled later than cTOFR. Therefore, it is suggested that the mTOFR value is a better determinant for safe extubation.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

  • Age: 18 - 65 (not including 65)
  • BMI: 18.5-24.9

Exclusion Criteria7

  • Liver and kidney disease
  • Non-consenting
  • Emergency surgeries
  • Muscle disease
  • Allergy to rocuronium and sugammadex
  • Patients predicted to have difficult mask ventilation or difficult intubation
  • Pregnant and breastfeeding women

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETOFscan monitoring

observation and data recording


Locations(1)

Ankara University

Ankara, Altındağ, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06220136


Related Trials